US firms query CBER artificial skin jurisdictional move
This article was originally published in Clinica
Executive Summary
AdvaMed is questioning the legality of moving the regulatory jurisdiction for artificial skin from the devices centre, CDRH, to the biologics centre, CBER, an issue now before the agency.